432 followers
DIFFERENTIAL benefit risk assessment of DOACs in the treatment of venous thromboembolism focus on dabigatran. http://t.co/68Gj5P8ZiJ
DIFFERENTIAL benefit risk assessment of DOACs in the treatment of venous thromboembolism focus on dabigatran. http://t.co/68Gj5P8ZiJ